Adam Pearce
SCAI statement seeks to guide physician operators and facilities on renal denervation use
The Society for Card...
Latest-generation DCBs “change thinking” on treatment of coronary artery disease
Interventional cardiol...
EuroPCR 2023: FAST-TAVI II highlights benefits of reducing length of stay after TAVI procedures
Implementation of a ...
HOSPITAVI elucidates underlying causes of rehospitalisations among TAVI patients
A single-centre retr...
TAVI pioneers discuss the past, present and future of transcatheter therapy
As transcatheter aor...
New consensus statement will take into account latest clinical trial evidence on renal denervation
A new consensus stat...
EuroPCR 2022: “Clear need” for transcatheter options for tricuspid regurgitation
“At the moment, tric...
EuroPCR 2022: Lifetime management is an important question for the evolution of TAVI
Matti Adam (Cologne,...
EuroPCR 2022: Sham controlled trials have “revitalised” interest in renal denervation
“Renal denervation h...
ACC 2021: VOYAGER-PAD analysis shows totality of ischaemic events reduced following rivaroxaban use
Rupert Bauersachs (Da...
Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVR
John Forrest (New Ha...
CRT 2021: Biodegradable polymer sirolimus-eluting stent shows ‘promising’ results in STEMI patients
Thomas Pilgrim (Bern, S...
Roxana Mehran on managing ischaemic benefit vs. bleeding harm in HBR patients (A three-part series)
Please NOTE: This video i...
PROGRESS PVL: One-year safety and performance outcomes for the ACURATE neo Aortic Valve System
NOTE: This video is ONLY ...
Study shows LAAO reduces major bleeding and mortality compared with NOACs in high-risk AF patients
Jens Erik Nielsen-Kud...
